MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status - PubMed (original) (raw)
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
H M Müller et al. Br J Cancer. 2003.
Abstract
This study analysed mRNA expression of two members of the methyl-CpG-binding protein family - MeCP2 and MBD2 - in human non-neoplastic (n=11) and neoplastic (n=57) breast tissue specimens using a quantitative real-time PCR method. We observed higher expression levels of MeCP2 mRNA in neoplastic tissues than in non-neoplastic tissues (P=0.001), whereas no significant differences for MBD2 were detected. When studying the relations between the most important clinicopathologic features of breast cancer and the mRNA expression level of both MBDs, we found that oestrogen receptor (OR)-positive breast cancer specimens contained higher levels of MeCP2 mRNA than did OR-negative cancers (P=0.005). Furthermore, we observed statistically significantly higher levels of MeCP2 in non-neoplastic tissues expressing high levels of OR as compared to those expressing low levels (P=0.017). Finally, using a linear regression model, we identified a statistically significant association between OR expression and MeCP2 mRNA expression in neoplastic and non-neoplastic breast tissue specimens (P=0.003). In conclusion, we were able to demonstrate for the first time that there exists a strong association between OR status and MeCP2 mRNA expression. Furthermore, we speculate that MeCP2, regulated by OR, plays a key role in the differentiation processes in human breast tissues.
Figures
Figure 1
Expression of MeCP2 mRNA in non-neoplastic (_n_=11) and neoplastic (_n_=57) breast tissue specimens. Expression levels were analysed using a quantitative real-time PCR method, as described in Materials and Methods. Expression levels were standardised using TBP expression. A strong correlation between the expression levels of MeCP2 and MBD2 mRNA was seen in both tissue types.
Figure 2
(A) Expression of MeCP2 mRNA in non-neoplastic (_n_=11) and neoplastic (_n_=57) breast tissue specimens. Expression levels were analysed using a quantitative real-time PCR method, as described in Materials and Methods. Expression levels were standardised using TBP expression. Outliers were excluded. (B) Expression of MBD2 mRNA in non-neoplastic (_n_=11) and neoplastic (_n_=57) breast tissue specimens. Outliers were excluded.
Figure 3
(A) Expression of MeCP2 mRNA in OR pos/neg neoplastic breast tissue specimens (_n_=57). Expression levels were analysed using a quantitative real-time PCR method, as described in Materials and Methods. Expression levels were standardised using TBP expression. Outliers were excluded. (B) Expression of MeCP2 mRNA in non-neoplastic (_n_=11) breast tissue specimens as a function of OR mRNA expression. Outliers were excluded.
Figure 4
Expression of MeCP2 mRNA in grade I (_n_=25) and grade III (_n_=10) breast cancer lesions. Expression levels were analysed using a quantitative real-time PCR method, as described in Materials and Methods. Expression levels were standardised using TBP expression. Outliers were excluded.
Similar articles
- Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG. Fang JY, et al. World J Gastroenterol. 2004 Dec 1;10(23):3394-8. doi: 10.3748/wjg.v10.i23.3394. World J Gastroenterol. 2004. PMID: 15526354 Free PMC article. - MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM, Magdinier F, Lenoir GM, Frappart L, Dante R. Billard LM, et al. Oncogene. 2002 Apr 18;21(17):2704-12. doi: 10.1038/sj.onc.1205357. Oncogene. 2002. PMID: 11965543 - Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C, Kügler K, Diederichs S, Klümpen S, Möller M, Vogt U, Metzger R, Schneider PM, Berdel WE, Serve H. Müller-Tidow C, et al. Br J Cancer. 2001 Oct 19;85(8):1168-74. doi: 10.1054/bjoc.2001.2041. Br J Cancer. 2001. PMID: 11710831 Free PMC article. - Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F, Green R, Cotterman RF, Pogribny IP, James SJ, Miller JW. Esfandiari F, et al. Carcinogenesis. 2003 Dec;24(12):1935-40. doi: 10.1093/carcin/bgg163. Epub 2003 Aug 29. Carcinogenesis. 2003. PMID: 12949043 - Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
Patra SK, Patra A, Zhao H, Carroll P, Dahiya R. Patra SK, et al. Biochem Biophys Res Commun. 2003 Mar 21;302(4):759-66. doi: 10.1016/s0006-291x(03)00253-5. Biochem Biophys Res Commun. 2003. PMID: 12646234
Cited by
- Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients.
Goebel G, Berger R, Strasak AM, Egle D, Müller-Holzner E, Schmidt S, Rainer J, Presul E, Parson W, Lang S, Jones A, Widschwendter M, Fiegl H. Goebel G, et al. Br J Cancer. 2012 Jan 3;106(1):189-98. doi: 10.1038/bjc.2011.510. Epub 2011 Nov 22. Br J Cancer. 2012. PMID: 22108517 Free PMC article. - Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation.
Wood KH, Zhou Z. Wood KH, et al. Front Genet. 2016 May 26;7:93. doi: 10.3389/fgene.2016.00093. eCollection 2016. Front Genet. 2016. PMID: 27303433 Free PMC article. Review. - Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG. Fang JY, et al. World J Gastroenterol. 2004 Dec 1;10(23):3394-8. doi: 10.3748/wjg.v10.i23.3394. World J Gastroenterol. 2004. PMID: 15526354 Free PMC article. - DNA methylation in human diseases.
Younesian S, Mohammadi MH, Younesian O, Momeny M, Ghaffari SH, Bashash D. Younesian S, et al. Heliyon. 2024 Jun 4;10(11):e32366. doi: 10.1016/j.heliyon.2024.e32366. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38933971 Free PMC article. Review. - Regulation of estrogen receptor alpha gene expression in the mouse prefrontal cortex during early postnatal development.
Westberry JM, Wilson ME. Westberry JM, et al. Neurogenetics. 2012 May;13(2):159-67. doi: 10.1007/s10048-012-0323-z. Epub 2012 Mar 29. Neurogenetics. 2012. PMID: 22457017
References
- Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–188 - PubMed
- Amir RE, Zoghbi HY (2000) Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype–genotype correlations. Am J Med Genet 97: 147–152 - PubMed
- Bieche I, Franc B, Vidaud D, Vidaud M, Lidereau R (2001) Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid 11: 147–152 - PubMed
- Billard LM, Magdinier F, Lenoir GM, Frappart L, Dante R (2002) MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene 21: 2704–2712 - PubMed
- Bird AP, Wolffe AP (1999) Methylation-induced repression – belts, braces, and chromatin. Cell 99: 451–454 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous